List of Tables
    Table 1. Gene Therapy in Oncology Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Gene Therapy in Oncology Market Trends
    Table 3. Gene Therapy in Oncology Market Drivers
    Table 4. Gene Therapy in Oncology Market Challenges
    Table 5. Gene Therapy in Oncology Market Restraints
    Table 6. Global Gene Therapy in Oncology Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Gene Therapy in Oncology Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Gene Therapy in Oncology Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Gene Therapy in Oncology Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Gene Therapy in Oncology Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Gene Therapy in Oncology Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Gene Therapy in Oncology Revenue Share by Player, 2017-2022
    Table 13. Global Gene Therapy in Oncology Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Gene Therapy in Oncology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Oncology as of 2021)
    Table 15. Top Players of Gene Therapy in Oncology in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Gene Therapy in Oncology Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Gene Therapy in Oncology Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Gene Therapy in Oncology Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Gene Therapy in Oncology Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Gene Therapy in Oncology Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Gene Therapy in Oncology Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Gene Therapy in Oncology Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Gene Therapy in Oncology Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Gene Therapy in Oncology Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Gene Therapy in Oncology Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Gene Therapy in Oncology Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Gene Therapy in Oncology Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Bristol-Myers Squibb Company Details
    Table 31. Bristol-Myers Squibb Business Overview
    Table 32. Bristol-Myers Squibb Gene Therapy in Oncology Product
    Table 33. Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 34. Bristol-Myers Squibb Recent Development
    Table 35. Cold Genesys Company Details
    Table 36. Cold Genesys Business Overview
    Table 37. Cold Genesys Gene Therapy in Oncology Product
    Table 38. Cold Genesys Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 39. Cold Genesys Recent Development
    Table 40. Advantagene Company Details
    Table 41. Advantagene Business Overview
    Table 42. Advantagene Gene Therapy in Oncology Product
    Table 43. Advantagene Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 44. Advantagene Recent Development
    Table 45. Amgen Company Details
    Table 46. Amgen Business Overview
    Table 47. Amgen Gene Therapy in Oncology Product
    Table 48. Amgen Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 49. Amgen Recent Development
    Table 50. AstraZeneca Company Details
    Table 51. AstraZeneca Business Overview
    Table 52. AstraZeneca Gene Therapy in Oncology Product
    Table 53. AstraZeneca Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 54. AstraZeneca Recent Development
    Table 55. Bio-Path Holdings Company Details
    Table 56. Bio-Path Holdings Business Overview
    Table 57. Bio-Path Holdings Gene Therapy in Oncology Product
    Table 58. Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 59. Bio-Path Holdings Recent Development
    Table 60. CRISPR Therapeutics Company Details
    Table 61. CRISPR Therapeutics Business Overview
    Table 62. CRISPR Therapeutics Gene Therapy in Oncology Product
    Table 63. CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 64. CRISPR Therapeutics Recent Development
    Table 65. Editas Medicine Company Details
    Table 66. Editas Medicine Business Overview
    Table 67. Editas Medicine Gene Therapy in Oncology Product
    Table 68. Editas Medicine Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 69. Editas Medicine Recent Development
    Table 70. Geron Corp Company Details
    Table 71. Geron Corp Business Overview
    Table 72. Geron Corp Gene Therapy in Oncology Product
    Table 73. Geron Corp Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 74. Geron Corp Recent Development
    Table 75. Idera Pharmaceuticals Company Details
    Table 76. Idera Pharmaceuticals Business Overview
    Table 77. Idera Pharmaceuticals Gene Therapy in Oncology Product
    Table 78. Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 79. Idera Pharmaceuticals Recent Development
    Table 80. Intellia Therapeutics Company Details
    Table 81. Intellia Therapeutics Business Overview
    Table 82. Intellia Therapeutics Gene Therapy in Oncology Product
    Table 83. Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 84. Intellia Therapeutics Recent Development
    Table 85. Johnson & Johnson Company Details
    Table 86. Johnson & Johnson Business Overview
    Table 87. Johnson & Johnson Gene Therapy in Oncology Product
    Table 88. Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 89. Johnson & Johnson Recent Development
    Table 90. Marsala Biotech Company Details
    Table 91. Marsala Biotech Business Overview
    Table 92. Marsala Biotech Gene Therapy in Oncology Product
    Table 93. Marsala Biotech Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 94. Marsala Biotech Recent Development
    Table 95. Merck Company Details
    Table 96. Merck Business Overview
    Table 97. Merck Gene Therapy in Oncology Product
    Table 98. Merck Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 99. Merck Recent Development
    Table 100. Mologen AG Company Details
    Table 101. Mologen AG Business Overview
    Table 102. Mologen AG Gene Therapy in Oncology Product
    Table 103. Mologen AG Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 104. Mologen AG Recent Development
    Table 105. Oncolytics Biotech Company Details
    Table 106. Oncolytics Biotech Business Overview
    Table 107. Oncolytics Biotech Gene Therapy in Oncology Product
    Table 108. Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 109. Oncolytics Biotech Recent Development
    Table 110. Oncosec Company Details
    Table 111. Oncosec Business Overview
    Table 112. Oncosec Gene Therapy in Oncology Product
    Table 113. Oncosec Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 114. Oncosec Recent Development
    Table 115. Oncotelic Company Details
    Table 116. Oncotelic Business Overview
    Table 117. Oncotelic Gene Therapy in Oncology Product
    Table 118. Oncotelic Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 119. Oncotelic Recent Development
    Table 120. Shenzhen SiBiono GeneTech Company Details
    Table 121. Shenzhen SiBiono GeneTech Business Overview
    Table 122. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product
    Table 123. Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 124. Shenzhen SiBiono GeneTech Recent Development
    Table 125. Sillajen Biotherapeutics Company Details
    Table 126. Sillajen Biotherapeutics Business Overview
    Table 127. Sillajen Biotherapeutics Gene Therapy in Oncology Product
    Table 128. Sillajen Biotherapeutics Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 129. Sillajen Biotherapeutics Recent Development
    Table 130. Tocagen Company Details
    Table 131. Tocagen Business Overview
    Table 132. Tocagen Gene Therapy in Oncology Product
    Table 133. Tocagen Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 134. Tocagen Recent Development
    Table 135. UniQure Company Details
    Table 136. UniQure Business Overview
    Table 137. UniQure Gene Therapy in Oncology Product
    Table 138. UniQure Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 139. UniQure Recent Development
    Table 140. Ziopharm Oncology Company Details
    Table 141. Ziopharm Oncology Business Overview
    Table 142. Ziopharm Oncology Gene Therapy in Oncology Product
    Table 143. Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2017-2022) & (US$ Million)
    Table 144. Ziopharm Oncology Recent Development
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Gene Therapy in Oncology Product Picture
    Figure 2. Global Gene Therapy in Oncology Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Gene Therapy in Oncology Market Size 2017-2028 (US$ Million)
    Figure 4. United States Gene Therapy in Oncology Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Gene Therapy in Oncology Market Size 2017-2028 (US$ Million)
    Figure 6. United States Gene Therapy in Oncology Market Share in Global 2017-2028
    Figure 7. Gene Therapy in Oncology Report Years Considered
    Figure 8. Product Picture of Ex Vivo
    Figure 9. Product Picture of In Vivo
    Figure 10. Global Gene Therapy in Oncology Market Share by Type in 2022 & 2028
    Figure 11. Global Gene Therapy in Oncology Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Gene Therapy in Oncology Market Share by Type (2017-2028)
    Figure 13. United States Gene Therapy in Oncology Market Share by Type in 2022 & 2028
    Figure 14. United States Gene Therapy in Oncology Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Gene Therapy in Oncology Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals
    Figure 17. Product Picture of Diagnostics Centers
    Figure 18. Product Picture of Research Institutes
    Figure 19. Global Gene Therapy in Oncology Market Share by Application in 2022 & 2028
    Figure 20. Global Gene Therapy in Oncology Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Gene Therapy in Oncology Market Share by Application (2017-2028)
    Figure 22. United States Gene Therapy in Oncology Market Share by Application in 2022 & 2028
    Figure 23. United States Gene Therapy in Oncology Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Gene Therapy in Oncology Market Share by Application (2017-2028)
    Figure 25. North America Gene Therapy in Oncology Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Gene Therapy in Oncology Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Gene Therapy in Oncology Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Gene Therapy in Oncology Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Gene Therapy in Oncology Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Gene Therapy in Oncology Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 54. Cold Genesys Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 55. Advantagene Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 56. Amgen Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 57. AstraZeneca Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 58. Bio-Path Holdings Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 59. CRISPR Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 60. Editas Medicine Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 61. Geron Corp Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 62. Idera Pharmaceuticals Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 63. Intellia Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 65. Marsala Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 66. Merck Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 67. Mologen AG Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 68. Oncolytics Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 69. Oncosec Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 70. Oncotelic Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 71. Shenzhen SiBiono GeneTech Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 72. Sillajen Biotherapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 73. Tocagen Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 74. UniQure Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 75. Ziopharm Oncology Revenue Growth Rate in Gene Therapy in Oncology Business (2017-2022)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed